Page last updated: 2024-08-25

rosiglitazone and liproxstatin-1

rosiglitazone has been researched along with liproxstatin-1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feng, D; Li, Y; Liu, D; Ning, S; Sun, R; Tian, D; Tian, X; Wang, Z; Yao, J; Zhang, F; Zhao, Y	1

Other Studies

1 other study(ies) available for rosiglitazone and liproxstatin-1

Article	Year
Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Cell death and differentiation, 2019, Volume: 26, Issue:11 Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Coenzyme A Ligases; DNA-Binding Proteins; Ferroptosis; Humans; Intestines; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Models, Animal; Promoter Regions, Genetic; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Sp1 Transcription Factor; Spiro Compounds	2019

Article

Year

Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion.

Cell death and differentiation, 2019, Volume: 26, Issue:11

Topics: Animals; Caco-2 Cells; Cell Line, Tumor; Coenzyme A Ligases; DNA-Binding Proteins; Ferroptosis; Humans; Intestines; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Models, Animal; Promoter Regions, Genetic; Quinoxalines; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Sp1 Transcription Factor; Spiro Compounds

2019